Lung Cancer :: Pre-treatment blood test could guide lung cancer therapy
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has discovered a ?signature? of proteins in the blood that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies.